Is this your Brand? Log in to Hoodie!
Log in to HoodieDharma Pharmaceuticals
Data Snapshot for Mar 20, 2026
Overview
YoY sales plummeted 56.5%—now in the 250-500K tier. Despite a recent rank improvement from #7 to #4, the brand faces challenges with a 39.8% drop in monthly sales over the last three months.
Categories
- Top Category: Edibles
- Price Tier: Premium
- States Active: 1
Top States
Dharma Pharmaceuticals Top StatesFeb 2026
Top states where Dharma Pharmaceuticals is active based on indexed sales coverage.
Trend View
Market Insights SnapshotFeb 2026
Trend narrative unavailable.
24-Month Trend
Average Price
$83.46
YoY Sales Trend
56.5%
2Y Sales Trend
22.6%
Edibles dominate at 52% of total sales, skyrocketing by 299.7% YoY. In stark contrast, Flower sales fell 61.8% YoY, highlighting a significant shift in consumer preferences.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Edibles | 52.2% | $95.39 | 299.7% |
| Flower | 44.0% | $80.78 | 61.8% |
| Topicals | 2.7% | $36.9 | 47.6% |
Virginia is the sole market for DHARMA PHARMACEUTICALS, accounting for 100% of sales. Geographic concentration is absolute, with no additional states in the footprint.
| State | Edibles | Flower | Topicals |
|---|---|---|---|
| 4 | 12 | 2 |
Want SKU-Level Buyer Signals?
Unlock purchaser contacts, SKU-level velocity, and whitespace opportunities for this brand.
Market Position
Competitive LandscapeFeb 2026
Ranked #4 in Edibles, DHARMA PHARMACEUTICALS is gaining ground, now just 3 spots behind leader ENCORE EDIBLES. Competing closely with HEDY and TASTEOLOGY, the brand shows promise in a challenging landscape.
SKU View
Notable ProductsFeb 2026
Top products for Feb 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1 | Flower | 176.8% |
#2 | Flower | 1.0% |
#3 | Edibles | 61.9% |
#4 | Edibles | 77.2% |
#5 | Edibles | 204.3% |
#6 | Edibles | 15.2% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Dharma Pharmaceuticals using competitive landscape rank coverage, proximity, and momentum.